Injectable Steroids
Latest laboratory result 195.52 mg/mL August 24, 2026 · 97.76% of label claim View
Primobolan 200
Product Details Dragon Pharma
Active Substance Methenolone Enanthate
Strength 200 mg/mL
Package 10 mL vial
Form Oil-based injectable
Estimated Half-Life Approximately 5–7 days
Water Retention Low
Aromatization No Does not convert to estrogen
Primary Concerns Blood pressure, lipids and androgenic effects
Potential effects and adverse reactions vary between individuals.
$350.00
Shipping Location :
International
U.S. Domestic
Dragon Pharma Primobolan 200 – Methenolone Enanthate 200 mg/mL
✔ 200 mg/mL ✔ 10 mL vial ✔ Injectable formulation ✔ Multiple analytical reports
Primobolan 200 by Dragon Pharma is an injectable product containing 200 mg/mL of Methenolone Enanthate. Methenolone Enanthate is a long-acting esterified form of methenolone, an anabolic-androgenic steroid derived from dihydrotestosterone (DHT).
Each vial contains 10 mL of solution at the stated concentration of 200 mg/mL. Compared with Primobolan 100, this presentation provides twice the labeled concentration of Methenolone Enanthate per milliliter while using the same active substance and enanthate ester.
Methenolone does not aromatize into estrogen, which distinguishes it from compounds such as testosterone and Methandienone. The absence of aromatization may reduce estrogen-mediated effects such as fluid retention from methenolone itself, but it does not mean that the product is free from significant hormonal, cardiovascular, androgenic, or injection-related risks.
Customers comparing injectable formulations can browse the broader injectable products category, including products such as Enantat 250, Masteron, and lower-strength Methenolone Enanthate presentations. These products differ in active substance, concentration, or pharmacological characteristics and should not be treated as direct substitutes.
About the Active Substance
Methenolone Enanthate combines methenolone with an enanthate ester that slows release after administration. It is generally described as having anabolic activity with comparatively lower androgenic activity than many other anabolic-androgenic steroids.
Because methenolone itself does not convert to estrogen, it is commonly associated with less estrogen-mediated water retention than aromatizing anabolic steroids. It can nevertheless suppress endogenous hormone production and may adversely affect cholesterol, cardiovascular risk factors, fertility, skin, hair, and other aspects of health.
Key Product Characteristics
- 200 mg/mL of Methenolone Enanthate
- 10 mL manufacturer vial
- Long-acting injectable formulation
- Does not aromatize into estrogen
- Multiple analytical potency reports available
- Latest listed result: 195.52 mg/mL
Latest Listed Test: August 24, 2026
The latest listed analytical report measured 195.52 mg/mL, equivalent to 97.76% of the stated 200 mg/mL label strength. The submitted sample was identified as batch METH200HD6.
Important: This page provides product-identification, analytical, and risk information only. It is not medical advice, a personalized dosing protocol, or a recommendation to use anabolic steroids.
Product Details
Active Substance
Methenolone Enanthate
Alternative Name
Metenolone Enanthate
Label Strength
200 mg/mL
Dosage Form
Injectable solution
Presentation
10 mL vial
Brand
Dragon Pharma
Latest Measured Result
195.52 mg/mL
Latest Assay vs Label
97.76%
Latest Listed Test Date
2026-08-24
Tested Batch
METH200HD6
Drug Class
Anabolic-androgenic steroid
Product identification: Confirm that the product name, active substance, strength, vial volume, packaging, seals, and available batch information correspond with the item received. Do not use a vial that is damaged, leaking, contaminated, unexpectedly opened, or unidentified.
Use, Health Risks & Medical Considerations
Medical supervision is strongly advised. Methenolone Enanthate can affect reproductive hormones, cholesterol, cardiovascular health, fertility, skin, hair, mood, and other aspects of health. General online protocols cannot account for a person's medical history, medications, laboratory values, or individual risk factors.
How Methenolone Enanthate Is Commonly Described
Methenolone Enanthate is a long-acting injectable anabolic-androgenic steroid. In performance-oriented settings, it is commonly associated with maintenance or gradual increases in lean tissue rather than the rapid scale-weight changes associated with compounds that produce substantial fluid retention.
The 200 mg/mL concentration changes the amount of active substance contained in each milliliter compared with Primobolan 100, but it does not change the underlying pharmacological identity of Methenolone Enanthate.
Unlike testosterone and some other anabolic steroids, methenolone does not aromatize into estrogen. This characteristic is commonly associated with lower estrogen-mediated fluid retention, but it should not be interpreted as evidence that Methenolone Enanthate is medically safe or free from systemic adverse effects.
Performance-oriented users sometimes discuss Methenolone Enanthate alongside testosterone products such as Enantat 250 or other anabolic steroids such as Anavar. Combining anabolic substances increases complexity and may intensify cardiovascular, hormonal, androgenic, hepatic, or other health risks.
Important Risk Areas
- Cardiovascular system: Anabolic steroids can adversely affect HDL and LDL cholesterol, blood pressure, vascular function, and overall cardiovascular risk.
- Hormonal system: Methenolone can suppress natural testosterone production and may affect fertility, libido, mood, and sexual function.
- Androgenic effects: Acne, oily skin, increased body-hair growth, and accelerated scalp-hair loss in genetically predisposed individuals may occur.
- Female-specific effects: Virilizing effects can occur and may include voice changes, increased body or facial hair, menstrual disturbances, and clitoral enlargement. Some changes may be irreversible.
- Injection-related risks: Injectable products carry risks including pain, irritation, infection, abscess formation, tissue injury, and complications associated with non-sterile administration.
- Psychological effects: Mood changes, irritability, anxiety, aggression, depression, or sleep disturbances may occur during or after anabolic-steroid exposure.
Monitoring Considerations
A licensed clinician may consider reviewing blood pressure, complete blood count, fasting lipids, liver and kidney markers, glucose markers, and reproductive hormone levels based on the individual's circumstances.
Testing does not make non-medical steroid use safe, but appropriate medical assessment may identify emerging health problems that would otherwise remain unnoticed.
Drug and Health Interactions
Risk may be greater in people with cardiovascular disease, high blood pressure, abnormal cholesterol, liver or kidney disease, clotting disorders, prostate conditions, diabetes, psychiatric conditions, or a history of hormone-sensitive disease.
Potential interactions may occur with anticoagulants, diabetes medications, corticosteroids, hormone therapies, and other performance-enhancing substances. A qualified clinician or pharmacist should review possible interactions.
Hormonal Recovery Considerations
Methenolone Enanthate can suppress endogenous hormone production. Products such as Nolvadex, Clomid, and other hormone-related medications are sometimes discussed in connection with post-use recovery, but they are separate medications with their own contraindications and adverse effects.
No universal estrogen-control or post-cycle protocol is appropriate for every person. Self-prescribing additional medications can mask symptoms, worsen hormone imbalance, or create further drug interactions.
Who Should Not Use It
- Children and adolescents
- People who are pregnant, trying to become pregnant, or breastfeeding
- People with uncontrolled high blood pressure or significant cardiovascular disease
- Anyone with serious liver or kidney disease
- Anyone with prostate, breast, or another hormone-sensitive cancer
- Competitive athletes subject to anti-doping rules
- Anyone using the product without understanding applicable local laws
When to Seek Urgent Medical Care
Seek urgent medical attention for chest pain, severe shortness of breath, fainting, one-sided weakness, severe headache, jaundice, rapidly worsening swelling, severe mood disturbance, signs of a serious allergic reaction, or an injection site that becomes increasingly painful, hot, swollen, or accompanied by fever.
No universal cycle or PCT schedule is provided here. Dose selection, treatment of adverse effects, and management of hormone suppression are medical matters that should be addressed by a qualified professional.
Analytical Potency Reports
The reports below display the measured concentration reported for submitted samples of Dragon Pharma Primobolan 200. The newest listed report appears first, followed by earlier reports for historical comparison.
A potency result evaluates the measured amount of the reported active substance in the submitted sample. It does not independently establish clinical safety, manufacturing compliance, legal status, sterility, freedom from every possible contaminant, or suitability for use.
Test Date
2026-08-24
Label Strength
200 mg/mL
Measured Result
195.52 mg/mL
Assay vs Label
97.76%
Batch
METH200HD6
Report summary: The submitted Primobolan 200 sample from batch METH200HD6 measured 195.52 mg/mL against the stated 200 mg/mL label strength.
Latest Report
Previous Reports
Test Date
2025-09-25
Label Strength
200 mg/mL
Measured Result
225.16 mg/mL
Assay vs Label
112.58%
Report summary: The submitted sample measured 225.16 mg/mL, equivalent to 112.58% of the stated 200 mg/mL label strength.
Previous Report
Test Date
2024-10-30
Label Strength
200 mg/mL
Measured Result
209.74 mg/mL
Assay vs Label
104.87%
Report summary: The submitted sample measured 209.74 mg/mL, equivalent to 104.87% of the stated 200 mg/mL label strength.
Previous Report
Additional analytical documents can be viewed in the Dragon Pharma lab report archive. Results should be interpreted together with the test date, submitted sample, batch information, laboratory method, and scope of analysis.
Authenticity, Delivery Information & Legal Notice
United States legal notice: Anabolic steroids are controlled substances under federal law. Possession, importation, distribution, or use without lawful authorization may carry criminal, civil, sporting, employment, or professional consequences. State laws may impose additional restrictions.
Product-Identification Checks
- Compare the product name and stated strength with the order and packaging
- Confirm that the vial identifies Dragon Pharma and Methenolone Enanthate
- Check that the label states 200 mg/mL and a 10 mL presentation
- Inspect the vial, cap, seal, print quality, and overall packaging condition
- Look for available batch or date information where present
- Compare analytical documents only with the corresponding product and submitted sample
- Do not use products that appear opened, relabeled, leaking, contaminated, or damaged
Authenticity limitation: Packaging photographs and third-party potency reports may support product evaluation, but neither alone can guarantee the identity, sterility, or condition of every item in circulation.
Verify Carefully
Delivery and Tracking Information
Delivery times, tracking availability, customs handling, and reshipment eligibility depend on the selected warehouse, destination, carrier, and current store policy. Review the complete Shipping Information page before placing an order.
Tracking events may not appear immediately, and some carriers scan parcels only after they reach a regional or destination facility. A temporary lack of tracking activity does not by itself confirm that a shipment has been lost.
Sports Eligibility
Methenolone is prohibited in competitive sport under anti-doping rules. Athletes are responsible for every prohibited substance detected in their samples, regardless of how the substance was obtained or labeled.
Additional Store Information
For broader information about product verification, store policies, and supporting sources, review the site's References, Terms and Conditions, and Privacy Policy.
Medical Disclaimer
Nothing on this page should be interpreted as diagnosis, treatment, prescribing guidance, or an assurance that this product is appropriate for a particular person. Consult a qualified clinician and verify the laws that apply in your jurisdiction.
Storage & Handling
Keep Primobolan 200 in its original labeled vial and packaging unless the manufacturer labeling specifies otherwise. Protect the product from excessive heat, direct sunlight, and inappropriate storage conditions.
- Keep the vial in its original labeled packaging
- Protect from excessive heat and direct sunlight
- Do not use a vial with a damaged or compromised closure
- Do not combine the contents of different vials or batches
- Keep away from children, pets, and unauthorized users
- Do not use solution that appears unexpectedly discolored, contaminated, or contains unexplained visible material
Do not use the product if the vial has been opened unexpectedly, the closure appears compromised, the label is unreadable, or the contents differ materially from their expected appearance.
For disposal guidance, contact a pharmacist or an authorized medication take-back service. Do not share controlled substances with another person.
Storage instructions printed on the original product packaging should take priority when they are more specific.
Frequently Asked Questions
What does Dragon Pharma Primobolan 200 contain?
Primobolan 200 is labeled to contain 200 mg/mL of Methenolone Enanthate and is supplied in a 10 mL vial.
How does Primobolan 200 differ from Primobolan 100?
Both products contain Methenolone Enanthate. Primobolan 200 is labeled at 200 mg/mL, while Primobolan 100 is labeled at 100 mg/mL. The primary difference is therefore the amount of active substance contained in each milliliter.
What did the latest Primobolan 200 lab report measure?
The report dated August 24, 2026, measured 195.52 mg/mL for batch METH200HD6. That equals 97.76% of the stated 200 mg/mL label strength for the submitted sample.
Are previous Primobolan 200 laboratory reports available?
Yes. Earlier listed reports include a September 25, 2025 result of 225.16 mg/mL and an October 30, 2024 result of 209.74 mg/mL. These reports provide historical analytical information for separate submitted samples.
Does a potency test prove that every vial is safe?
No. A potency result applies to the submitted sample and the scope of the analysis. It does not by itself establish clinical safety, manufacturing compliance, legal status, sterility, freedom from every possible contaminant, or suitability for an individual user.
Does Methenolone Enanthate aromatize?
Methenolone does not aromatize into estrogen. This means estrogen-mediated effects are not expected through conversion of methenolone itself, but the compound can still produce significant hormonal, cardiovascular, androgenic, and other adverse effects.
Can Primobolan 200 suppress natural testosterone production?
Yes. Like other anabolic-androgenic steroids, Methenolone Enanthate can suppress endogenous testosterone production and may affect fertility, libido, mood, and sexual function.
What are the main health concerns?
Important concerns include unfavorable cholesterol changes, cardiovascular risk, hormonal suppression, fertility effects, acne, oily skin, scalp-hair loss in predisposed individuals, virilization in women, and risks associated with injectable products.
Is Methenolone Enanthate legal in the United States?
Anabolic steroids are federally controlled substances in the United States. Possession, importation, distribution, or use without lawful authorization may violate federal or state law. Users should obtain current legal advice for their jurisdiction.
Where can I review the delivery policy?
Current information about processing, tracking, expected delivery, customs issues, and reshipment eligibility is available on the Shipping Information page.
Is Methenolone permitted in tested sports?
No. Methenolone is prohibited under anti-doping rules. Competitive athletes remain responsible for prohibited substances found in their samples.
Related Offers
Lab Tested
Domestic & International
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Nandrolone Decanoate Long-acting nandrolone ester
Strength 300 mg/mL
Package 10 mL vial 3,000 mg total labeled content
Form Oil-based injectable
Estimated Half-Life Approximately 6–10 days
Drug Class Androgen & anabolic steroid
Water Retention Possible
Aromatization Low
$66.00
Lab Tested
Shipped USA Domestic
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Stanozolol Also known as Winstrol
Strength 50 mg/mL
Package 10 mL vial 500 mg total labeled content
Form Injectable suspension
Estimated Half-Life Approximately 9 hours
Drug Class Androgen & anabolic steroid
Water Retention Low
Aromatization No
$116.00
Lab Tested
Domestic & International
Buy 3 and get 1 for FREE
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Boldenone Undecylenate Long-acting boldenone ester
Strength 300 mg/mL
Package 10 mL vial 3,000 mg total labeled content
Form Oil-based injectable
Estimated Half-Life Approximately 14 days
Drug Class Androgen & anabolic steroid
Water Retention Low
Aromatization Low
$66.00
Shipped USA Domestic
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Drostanolone Propionate Short-acting drostanolone ester
Strength 100 mg/mL
Package 10 mL vial 1,000 mg total labeled content
Form Oil-based injectable
Estimated Half-Life Approximately 1–2 days
Drug Class Androgen & anabolic steroid
Water Retention Low
Aromatization No
$142.00
Lab Tested
Domestic & International
Buy 2 and get 1 for FREE
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Drostanolone Enanthate Long-acting drostanolone ester
Strength 200 mg/mL
Package 10 mL vial 2,000 mg total labeled content
Form Oil-based injectable
Estimated Half-Life Approximately 7–10 days Enanthate ester
Water Retention Low Does not aromatize to estrogen
Aromatization No Non-aromatizing DHT-derived compound
Primary Concerns Androgenic effects and lipids
$125.00
Lab Tested
Domestic & International
Buy 3 and get 1 for FREE
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Nandrolone Phenylpropionate NPP
Strength 150 mg/mL
Package 10 mL vial 1,500 mg total labeled content
Form Oil-based injectable
Estimated Half-Life Approximately 2–4 days Short-acting nandrolone ester
Water Retention Possible Individual response varies
Aromatization Low Lower than testosterone
Primary Concerns Hormonal suppression, prolactin and lipids
$46.00
Lab Tested
Shipped USA Domestic
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Methenolone Enanthate
Strength 100 mg/mL
Package 10 mL vial
Form Oil-based injectable
Estimated Half-Life Approximately 5–7 days
Water Retention Low
Aromatization No Does not convert to estrogen
Primary Concerns Blood pressure, lipids and androgenic effects
Potential effects and adverse reactions vary between individuals.
$279.00
Lab Tested
Domestic & International
Buy 3 and get 1 for FREE
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Trenbolone Acetate Short-acting trenbolone ester
Strength 100 mg/mL
Package 10 mL vial 1,000 mg total labeled content
Form Oil-based injectable
Estimated Half-Life Approximately 1–2 days
Drug Class Androgen & anabolic steroid
Water Retention Low
Aromatization No
$100.00
February 2, 2025
Using Primobolan 200 has led to substantial muscle growth and increased strength. The gains are clean and well-defined, and I have more energy during workouts. Recovery times are shorter, making it easier to stick to my training schedule. This product has made a significant impact on my progress and is highly recommended.